<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p77" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_77{left:130px;bottom:1196px;letter-spacing:-0.15px;}
#t2_77{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_77{left:238px;bottom:1115px;letter-spacing:-0.01px;}
#t4_77{left:238px;bottom:1096px;letter-spacing:-0.01px;}
#t5_77{left:238px;bottom:1061px;letter-spacing:-0.01px;}
#t6_77{left:238px;bottom:1042px;letter-spacing:-0.01px;}
#t7_77{left:238px;bottom:1022px;letter-spacing:-0.01px;}
#t8_77{left:238px;bottom:1003px;letter-spacing:-0.01px;}
#t9_77{left:238px;bottom:983px;letter-spacing:-0.01px;}
#ta_77{left:475px;bottom:983px;letter-spacing:-0.01px;}
#tb_77{left:238px;bottom:964px;letter-spacing:-0.01px;}
#tc_77{left:238px;bottom:944px;letter-spacing:-0.01px;}
#td_77{left:238px;bottom:925px;letter-spacing:-0.01px;}
#te_77{left:238px;bottom:871px;letter-spacing:-0.01px;}
#tf_77{left:238px;bottom:851px;letter-spacing:-0.01px;}
#tg_77{left:238px;bottom:832px;letter-spacing:-0.01px;}
#th_77{left:238px;bottom:813px;letter-spacing:-0.01px;}
#ti_77{left:238px;bottom:793px;letter-spacing:-0.01px;}
#tj_77{left:238px;bottom:774px;letter-spacing:-0.01px;}
#tk_77{left:238px;bottom:754px;letter-spacing:-0.01px;}
#tl_77{left:238px;bottom:735px;letter-spacing:-0.01px;}
#tm_77{left:238px;bottom:715px;letter-spacing:-0.01px;}
#tn_77{left:238px;bottom:696px;letter-spacing:-0.01px;}
#to_77{left:238px;bottom:677px;letter-spacing:-0.01px;}
#tp_77{left:238px;bottom:657px;letter-spacing:-0.01px;}
#tq_77{left:238px;bottom:638px;letter-spacing:-0.01px;}
#tr_77{left:238px;bottom:618px;letter-spacing:-0.01px;}
#ts_77{left:238px;bottom:599px;letter-spacing:-0.01px;}
#tt_77{left:238px;bottom:579px;letter-spacing:-0.01px;}
#tu_77{left:238px;bottom:560px;letter-spacing:-0.01px;}
#tv_77{left:238px;bottom:486px;letter-spacing:-0.01px;}
#tw_77{left:238px;bottom:452px;letter-spacing:-0.01px;}
#tx_77{left:238px;bottom:432px;letter-spacing:-0.01px;}
#ty_77{left:238px;bottom:413px;letter-spacing:-0.01px;}
#tz_77{left:238px;bottom:393px;letter-spacing:-0.01px;}
#t10_77{left:238px;bottom:374px;letter-spacing:-0.01px;}
#t11_77{left:238px;bottom:354px;letter-spacing:-0.01px;}
#t12_77{left:238px;bottom:335px;letter-spacing:-0.01px;}
#t13_77{left:238px;bottom:316px;letter-spacing:-0.01px;}
#t14_77{left:238px;bottom:296px;letter-spacing:-0.01px;}
#t15_77{left:238px;bottom:223px;letter-spacing:-0.01px;}
#t16_77{left:238px;bottom:203px;letter-spacing:-0.01px;}
#t17_77{left:238px;bottom:184px;letter-spacing:-0.01px;}
#t18_77{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_77{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_77{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_77{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_77{font-size:13px;font-family:NotoSans-Regular_7j-_1;color:#000;}
.s4_77{font-size:11px;font-family:NotoSans-Regular_7j-_1;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts77" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

@font-face {
	font-family: NotoSans-Regular_7j-_1;
	src: url("fonts/NotoSans-Regular_7j-_1.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg77Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg77" style="-webkit-user-select: none;"><object width="908" height="1286" data="77/77.svg" type="image/svg+xml" id="pdf77" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_77" class="t s0_77">7.3. Fundamental considerations of multimodal therapy approaches </span><span id="t2_77" class="t s1_77">77 </span>
<span id="t3_77" class="t s2_77">cases may lead to permanent tracheostomy and the wearing of a blocked tracheostomy tube </span>
<span id="t4_77" class="t s2_77">[256-258]. </span>
<span id="t5_77" class="t s2_77">In the 10-year data from the RTOG-9111 [188] laryngeal organ preservation study discussed </span>
<span id="t6_77" class="t s2_77">above, it was also apparent that the rate of late, non-tumor-related deaths in the </span>
<span id="t7_77" class="t s2_77">simultaneous arm was 36% compared to the other two arms (18% each). Due to the </span>
<span id="t8_77" class="t s2_77">equivalence of the two combination arms (simultaneous and sequential) in terms of the </span>
<span id="t9_77" class="t s2_77">endpoint “laryngectomy free survival”, </span><span id="ta_77" class="t s3_77">this led to an ongoing discussion about the toxicity- </span>
<span id="tb_77" class="t s3_77">related advantages of an induction protocol for laryngeal organ preservation. Even if the exact </span>
<span id="tc_77" class="t s3_77">causes remain unclear, the increased non-tumor-related death rate in the simultaneous arm is </span>
<span id="td_77" class="t s3_77">associated with the higher toxicity of the therapy. </span>
<span id="te_77" class="t s3_77">David Rosenthal from MD Anderson presented a retrospective, very extensive monocentric </span>
<span id="tf_77" class="t s3_77">study in which he divided the 221 T4a laryngeal carcinomas from 1983 to 2011 into the group of </span>
<span id="tg_77" class="t s3_77">patients who underwent primary surgery (n=161) and those who underwent primary </span>
<span id="th_77" class="t s3_77">radiochemotherapy (n=60) and compared them taking numerous parameters into account. </span>
<span id="ti_77" class="t s3_77">With the same median survival in both groups, 45% of the patients who were treated </span>
<span id="tj_77" class="t s3_77">conservatively had a permanent tracheostomy and an “any event” aspiration rate of 23%. The </span>
<span id="tk_77" class="t s3_77">rate of grade III/IV late dysphagia was significantly lower in the group of patients who </span>
<span id="tl_77" class="t s3_77">underwent primary surgery. It is noteworthy that when considering the endpoint </span>
<span id="tm_77" class="t s3_77">“laryngoesophageal dysfunction-free survival” defined by Ang and Lefebvre, only 15% met this </span>
<span id="tn_77" class="t s3_77">target criterion after 10 years (after 5 years, the figure was 35%). For the endpoint “actuarial </span>
<span id="to_77" class="t s3_77">freedom from laryngectomy”, i.e. the pure consideration “with or without salvage </span>
<span id="tp_77" class="t s3_77">laryngectomy”, 70% was achieved (after 5 years, 70% unchanged). The gradual deterioration in </span>
<span id="tq_77" class="t s3_77">functionality observed here, which lasted for many years, was impressively documented here. </span>
<span id="tr_77" class="t s3_77">The authors conclude that, for reasons of late toxicity and overall survival, laryngectomy is the </span>
<span id="ts_77" class="t s3_77">treatment of choice for T4 laryngeal carcinomas and that multimodal organ preservation only </span>
<span id="tt_77" class="t s3_77">appears justified in selected smaller T4 tumors with only minimal involvement of the thyroid </span>
<span id="tu_77" class="t s3_77">cartilage [259-261]. </span>
<span id="tv_77" class="t s3_77">Therapeutic options in case of late toxicity </span>
<span id="tw_77" class="t s3_77">The range of therapeutic options is currently limited. Rosenthal, Lewin and Eisbruch [262] </span>
<span id="tx_77" class="t s3_77">propose special care protocols in a study to reduce the occurrence of chronic dysphagia and </span>
<span id="ty_77" class="t s3_77">aspiration. Their approach includes close recording of swallowing difficulties and early speech </span>
<span id="tz_77" class="t s3_77">therapy interventions during and after therapy in order to optimize long-term function [251, </span>
<span id="t10_77" class="t s3_77">263]. However, this requires a basic understanding of the functionality of the swallowing act, </span>
<span id="t11_77" class="t s3_77">accompanying qualified functional diagnostics (phoniatrics and ENT) and interdisciplinary </span>
<span id="t12_77" class="t s3_77">therapy concepts. In particular, ongoing swallowing training during and after therapy (Cave: </span>
<span id="t13_77" class="t s3_77">prophylactic PEG placement) and early rehabilitation are said to be crucial for success [262, </span>
<span id="t14_77" class="t s3_77">264, 265]. </span>
<span id="t15_77" class="t s3_77">Finally, it should be noted that the cited studies are based on now outdated radiation </span>
<span id="t16_77" class="t s3_77">techniques, so that the late functionalities currently achievable with IMRT and parotid/ </span>
<span id="t17_77" class="t s3_77">constrictor protection should be less pronounced. </span>
<span id="t18_77" class="t s4_77">© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
